{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:12:09Z","timestamp":1780589529592,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00415-019-09283-3","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T12:04:51Z","timestamp":1552997091000},"page":"1459-1472","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A cluster of disseminated small cortical lesions in MELAS: its distinctive clinical and neuroimaging features"],"prefix":"10.1007","volume":"266","author":[{"given":"Yu","family":"Hongo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntaro","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Suga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsugio","family":"Akutsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Onozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohide","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoshi","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7234-0720","authenticated-orcid":false,"given":"Takahiro","family":"Iizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,19]]},"reference":[{"key":"9283_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ana.410160409","volume":"16","author":"SG Pavlakis","year":"1984","unstructured":"Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP (1984) Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 16:481\u2013488. \n                    https:\/\/doi.org\/10.1002\/ana.410160409","journal-title":"Ann Neurol"},{"key":"9283_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2217\/fnl.09.71","volume":"5","author":"T Iizuka","year":"2010","unstructured":"Iizuka T, Sakai F (2010) Pathophysiology of stroke-like episodes in MELAS: neuron-astrocyte uncoupling in neuronal hyperexcitability. Future Neurol 5:61\u201383. \n                    https:\/\/doi.org\/10.2217\/fnl.09.71","journal-title":"Future Neurol"},{"key":"9283_CR3","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/348651a0","volume":"348","author":"Y Goto","year":"1990","unstructured":"Goto Y, Nonaka I, Horai S (1990) A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348:651\u2013653","journal-title":"Nature"},{"key":"9283_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4161\/rna.2.2.1610","volume":"2","author":"Y Kirino","year":"2005","unstructured":"Kirino Y, Suzuki T (2005) Human mitochondrial diseases associated with tRNA wobble modification deficiency. RNA Biol 2:41\u201344","journal-title":"RNA Biol"},{"key":"9283_CR5","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/wrna.65","volume":"2","author":"T Suzuki","year":"2011","unstructured":"Suzuki T, Nagao A, Suzuki T (2011) Human mitochondrial diseases caused by lack of taurine modification in mitochondrial tRNAs. Wiley Interdiscip Rev RNA 2:376\u2013386. \n                    https:\/\/doi.org\/10.1002\/wrna.65","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"9283_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/BF00688185","volume":"74","author":"E Ohama","year":"1987","unstructured":"Ohama E, Ohara S, Ikuta F, Tanaka K, Nishizawa M, Miyatake T (1987) Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol 74:226\u2013233. \n                    https:\/\/doi.org\/10.1007\/BF00688185","journal-title":"Acta Neuropathol"},{"key":"9283_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005072-199301000-00001","volume":"52","author":"M Sparaco","year":"1993","unstructured":"Sparaco M, Bonilla E, Dimauro S, Powers JM (1993) Neuropathology of mitochondrial encephalopathies due to mitochondrial DNA defects. J Neuropathol Exp Neurol 52:1\u201310","journal-title":"J Neuropathol Exp Neurol"},{"key":"9283_CR8","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1212\/WNL.59.6.816","volume":"59","author":"T Iizuka","year":"2002","unstructured":"Iizuka T, Sakai F, Suzuki N, Hata T, Tsukahara S, Fukuda M, Takiyama Y (2002) Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome. Neurology 59:816\u2013824. \n                    https:\/\/doi.org\/10.1212\/WNL.59.6.816","journal-title":"Neurology"},{"key":"9283_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2174\/1567202052773544","volume":"2","author":"T Iizuka","year":"2005","unstructured":"Iizuka T, Sakai F (2005) Pathogenesis of stroke-like episodes in MELAS: analysis of neurovascular cellular mechanisms. Curr Neurovasc Res 2:29\u201345","journal-title":"Curr Neurovasc Res"},{"key":"9283_CR10","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1212\/01.WNL.0000091888.26232.FE","volume":"61","author":"T Iizuka","year":"2003","unstructured":"Iizuka T, Sakai F, Kan S, Suzuki N (2003) Slowly progressive spread of the stroke-like lesions in MELAS. Neurology 61:1238\u20131244. \n                    https:\/\/doi.org\/10.1212\/01.WNL.0000091888.26232.FE","journal-title":"Neurology"},{"key":"9283_CR11","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1212\/WNL.53.9.2182","volume":"53","author":"M Yoneda","year":"1999","unstructured":"Yoneda M, Maeda M, Kimura H, Fujii A, Katayama K, Kuriyama M (1999) Vasogenic edema on MELAS: a serial study with diffusion-weighted MR imaging. Neurology 53:2182\u20132184. \n                    https:\/\/doi.org\/10.1212\/WNL.53.9.2182","journal-title":"Neurology"},{"key":"9283_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1749-6632.2010.05624.x","volume":"1201","author":"Y Koga","year":"2010","unstructured":"Koga Y, Povalko N, Nishioka J, Katayama K, Kakimoto N, Matsuishi T (2010) MELAS and l-arginine therapy: pathophysiology of stroke-like episodes. Ann N Y Acad Sci 1201:104\u2013110. \n                    https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05624.x","journal-title":"Ann N Y Acad Sci"},{"key":"9283_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.mito.2009.08.006","volume":"9","author":"MM Davidson","year":"2009","unstructured":"Davidson MM, Walker WF, Hernandez-Rosa E (2009) The m.3243A>G mtDNA mutation is pathogenic in an in vitro model of the human blood brain barrier. Mitochondrion 9:463\u2013470. \n                    https:\/\/doi.org\/10.1016\/j.mito.2009.08.006","journal-title":"Mitochondrion"},{"key":"9283_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1055\/s-0030-1261886","volume":"41","author":"M Matsuzaki","year":"2010","unstructured":"Matsuzaki M, Takahashi R, Nakayama T, Shishikura K, Suzuki H, Hirayama Y, Osawa M, Oda H (2010) Disruption of endothelial tight junctions in a patient with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS). Neuropediatrics 41:72\u201374. \n                    https:\/\/doi.org\/10.1055\/s-0030-1261886","journal-title":"Neuropediatrics"},{"key":"9283_CR15","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1007\/s00415-018-9057-7","volume":"265","author":"Y Koga","year":"2018","unstructured":"Koga Y, Povalko N, Inoue E, Nakamura H, Ishii A, Suzuki Y, Yoneda M, Kanda F, Kubota M, Okada H, Fujii K (2018) Therapeutic regimen of l-arginine for MELAS: 9-year, prospective, multicenter, clinical research. Neurol J 265:2861\u20132874. \n                    https:\/\/doi.org\/10.1007\/s00415-018-9057-7","journal-title":"Neurol J"},{"key":"9283_CR16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/B978-0-12-801415-8.00021-7","volume":"547","author":"S Xie","year":"2014","unstructured":"Xie S (2014) MR OEF imaging in MELAS. Methods Enzymol 547:433\u2013444. \n                    https:\/\/doi.org\/10.1016\/B978-0-12-801415-8.00021-7","journal-title":"Methods Enzymol"},{"key":"9283_CR17","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1212\/01.WNL.0000078931.87815.B3","volume":"61","author":"T Iizuka","year":"2003","unstructured":"Iizuka T, Sakai F, Endo M, Suzuki N (2003) Response to sumatriptan in headache of MELAS syndrome. Neurology 61:577\u2013578. \n                    https:\/\/doi.org\/10.1212\/01.WNL.0000078931.87815.B3","journal-title":"Neurology"},{"issue":"Suppl 2","key":"9283_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/head.13081","volume":"57","author":"L Edvinsson","year":"2017","unstructured":"Edvinsson L (2017) The trigeminovascular pathway: role of CGRP and CGRP receptors in migraine. Headache 57(Suppl 2):47\u201355. \n                    https:\/\/doi.org\/10.1111\/head.13081","journal-title":"Headache"},{"key":"9283_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jns.2008.11.016","volume":"278","author":"T Iizuka","year":"2009","unstructured":"Iizuka T, Goto Y, Miyakawa S, Sato M, Wang Z, Suzuki K, Hamada J, Kurata A, Sakai F (2009) Progressive carotid artery stenosis with a novel tRNA phenylalanine mitochondrial DNA mutation. J Neurol Sci 278:35\u201340. \n                    https:\/\/doi.org\/10.1016\/j.jns.2008.11.016","journal-title":"J Neurol Sci"},{"key":"9283_CR20","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/brain\/aws110","volume":"135","author":"NZ Lax","year":"2012","unstructured":"Lax NZ, Pienaar IS, Reeve AK, Hepplewhite PD, Jaros E, Taylor RW, Kalaria RN, Turnbull DM (2012) Microangiopathy in the cerebellum of patients with mitochondrial DNA disease. Brain 135:1736\u20131750. \n                    https:\/\/doi.org\/10.1093\/brain\/aws110","journal-title":"Brain"},{"key":"9283_CR21","first-page":"479","volume":"21","author":"N Bargall\u00f3","year":"2000","unstructured":"Bargall\u00f3 N, Burrel M, Berenguer J, Cofan F, Bu\u00f1esch L, Mercader JM (2000) Cortical laminar necrosis caused by immunosuppressive therapy and chemotherapy. AJNR Am J Neuroradiol 21:479\u2013484","journal-title":"AJNR Am J Neuroradiol"},{"key":"9283_CR22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1136\/jnnp.2004.058701","volume":"77","author":"A Donaire","year":"2006","unstructured":"Donaire A, Carreno M, G\u00f3mez B, Fossas P, Bargall\u00f3 N, Agudo R, Falip M, Setoa\u00edn X, Boget T, Raspall T, Obach V, Rumi\u00e1 J (2006) Cortical laminar necrosis related to prolonged focal status epilepticus. J Neurol Neurosurg Psychiatry 77:104\u2013106. \n                    https:\/\/doi.org\/10.1136\/jnnp.2004.058701","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9283_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1517\/17425255.2012.644535","volume":"8","author":"J Finsterer","year":"2012","unstructured":"Finsterer J, Zarrouk Mahjoub S (2012) Mitochondrial toxicity of antiepileptic drugs and their tolerability in mitochondrial disorders. Expert Opin Drug Metab Toxicol 8:71\u201379. \n                    https:\/\/doi.org\/10.1517\/17425255.2012.644535","journal-title":"Expert Opin Drug Metab Toxicol"}],"updated-by":[{"DOI":"10.1007\/s00415-019-09314-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T00:00:00Z","timestamp":1554768000000}}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09283-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09283-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09283-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:04:33Z","timestamp":1584489873000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09283-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,19]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["9283"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09283-3","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00415-019-09314-z","asserted-by":"object"}]},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,19]]},"assertion":[{"value":"15 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2019","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author would like to correct the errors in the publication of the original article. The corrected details are given below for your reading.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"KN received grants from Daiichi Sankyo Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., and Eisai Co., Ltd. TI received a grant from Japan Epilepsy Research Foundation. Other authors report no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the Institutional Review Board of Kitasato University (B17-351).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}